HealthInternational

U.K. Becomes First Country to Approve Pfizer’s COVID-19 Vaccine

Vaccinations to Begin Next Week

Pfizer and BioNTech said Wednesday that the United Kingdom has approved emergency use of their coronavirus vaccine — the first time outside of clinical trials that anyone will have the chance to be inoculated.

A U.K. government spokesperson said the vaccine will be ready for British citizens next week, CNN reported.

“To aid the success of the vaccination program it is the vital everyone continues to play their part and abide by the necessary restrictions in their area so we can further suppress the virus and allow the National Health Service to do its work without being overwhelmed,” the spokesperson said, CNN reported.

The companies had previously signed an agreement to supply 40 million doses to the U.K. with delivery in 2020 and 2021.

Pfizer CEO Albert Bourla called the emergency authorization “a historic moment in the fight against COVID-19.”

As of Wednesday, roughly 64.2 million coronavirus cases and 1.5 million related deaths have been reported worldwide, according to a Johns Hopkins University tracker.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker